Sees FY25 revenue up 7%-10%. Backs FY25 adjusted EBITDA view 16.7%-17.3% of net revenue. The company said, “In setting Stantec’s (STN) targets and guidance, the Company assumed an average value for the US dollar of $1.41, GBP of $1.80, and AU of $0.90. For all other underlying assumptions, see the Q1 2025 MD&A. These targets do not include any assumptions for additional acquisitions, including Page and Ryan Hanley, or the impact of revaluing our share-based compensation.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STN:
- Stantec reports Q1 adjusted EPS C$1.16 vs. C$0.90 last year
- Stantec selected to lead design for Dundas Bus Rapid Transit project
- Stantec to Lead Design for Mississauga’s Dundas BRT Corridor
- Stantec price target raised to C$144 from C$143 at Scotiabank
- Stantec to design PFAS treatment system in Vancouver, WA